The idea of a compound that is nearly harmless but possibly relieves some of the country's tremendous burden of osteoarthritis pain is appealing.
Because individuals with existing cardiovascular disease (CVD) may be at particular risk for cardiovascular events if they use nonsteroidal anti-inflammatory drugs (NSAIDs), a recent article reviews the safety of NSAIDs in general, and particularly in this population.
According to a study published in the New England Journal of Medicine, by age 65 most physicians (75% in low-risk specialties and up to 99% in high-risk specialties) will have faced a medical malpractice claim.
“Opioids are a double-edged sword,” says William D. Chey, MD, Professor of Internal Medicine, University of Michigan Health System, Ann Arbor, MI. “Patients need these drugs to manage their pain, but the drugs have difficult side effects, of which constipation is one of the most bothersome.”
Several online social networks are catering to the unique needs of physicians via electronic communication to discuss patient cases, rare diseases, and more.
A dietary fiber from the tuberous root of the Amorphophallus konjac plant, glucomannan has multiple dietary functions and may help to treat comorbid conditions of type 2 diabetes, obesity, and heart disease.
Physical and mental comorbidities that affect treatment compliance and quality of life are common in patients with multiple sclerosis and are associated with adverse outcomes.
"I respect the [JNC8] authors, who are outstanding in their field. But the recommendations generated controversy and confusion among clinicians. Our new scientific statement is designed to review the most recent evidence and bring clarity to treatment of hypertension in patients with CAD."